Curious about today's AI digest?ai-tldr.dev
Pomegra LogoPomegra

Daily Digest

BriefMarket · neutralLow impact
Esc

Option Care Health Stock Jumps 33% After $5.8B Buyout Deal

SEC / Option Care Health2 min read6 sources

Why did Option Care Health stock jump 33%?

Option Care Health (OPCH) stock jumped 33% to about $31 on Tuesday after McKesson and CD&R agreed to buy the home infusion company for $32.05 a share in a $5.8 billion deal.

Key numbers

Offer price per share$32.05+37% vs Oct 5 close
Deal value incl. debt$5.8BEnterprise value
OPCH Tuesday move+33%Close near $31.07 (per [4])
McKesson investment$1.4BFor about 49% stake
Expected closingH1 2027Needs shareholder and regulatory approval

What happened

Option Care Health (OPCH) stock jumped 33% to about $31 on Tuesday after McKesson and CD&R agreed to buy the home infusion company for $32.05 a share in a $5.8 billion deal. The $32.05 cash price is 37% above Monday's close, and the $5.8 billion figure includes the company's debt. CD&R, a private equity firm, will own about 51%, and McKesson, a large drug distributor, will invest about $1.4 billion for the other 49%. Shares had already jumped more than 20% overnight after the Financial Times reported talks. Closing is expected in the first half of 2027.

Why it matters

Option Care Health is the largest independent U.S. provider of infusion care, meaning medicines given through an IV or injection, often at a patient's home. McKesson says the deal fits its push toward complex treatments in lower-cost settings outside hospitals. Because buyers are paying cash, the stock now trades near the $32.05 offer rather than moving with company results. Option Care also withdrew its financial forecast.

Who this affects

Marketneutral
Low impact
Little wider effect; stock now tracks the $32.05 offer.
Companybullish
High impact
Shareholders get a 37% premium; company goes private.
Competitorsneutral
Low impact
BrightSpring trades at a higher valuation than Option Care did.
Industrybullish
Medium impact
Home infusion draws big-name buyers; positive for the sector.

Option Care Health vs BrightSpring

Option Care HealthOPCH-15.8%+1.9%$5.76B11.3x
BrightSpring Health ServicesBTSG+34.2%+18.5%$15.3B26.3x

As of 2026-09-29

How we got here

  1. Financial Times reports deal talks; Option Care shares jump over 20% overnight.

  2. McKesson and CD&R announce $32.05-a-share deal; stock closes up about 33%.

  3. Option Care to release Q3 results, with no conference call and guidance withdrawn.

What to watch

  • Option Care's Q3 results, due without a live call after guidance was withdrawn.2026-11-04
  • Shareholder vote and regulatory approvals needed before the deal can close.H1 2027

Educational content only. Not investment advice.

More briefsAll briefs →